Improving Outcomes for Patients With Metastatic Colorectal Cancer: Challenges and Strategies

Leslie A Swanson; Kathleen Boyle

doi:10.6004/jadpro.2020.11.3.15

Improving Outcomes for Patients With Metastatic Colorectal Cancer: Challenges and Strategies

J Adv Pract Oncol. 2020 Apr;11(3):291-296. doi: 10.6004/jadpro.2020.11.3.15. Epub 2020 Apr 1.

Authors

Leslie A Swanson¹, Kathleen Boyle²

Affiliations

¹ University of Washington/Seattle Cancer Care Alliance.
² Dana-Farber Cancer Institute, Boston, Massachusetts.

Abstract

At JADPRO Live 2019, Leslie A. Swanson, ARNP, and Kathleen Boyle, PA-C, reviewed guideline-concordant molecular testing and therapy in patients with metastatic colorectal cancer (mCRC), the clinical significance of emerging data for existing and novel agents used to treat mCRC, and the management of adverse events associated with mCRC therapies.